AGIO:NASDAQ
Agios Pharmaceuticals Inc
၃၂.၉၇ US$
arrow_downward
-၁.၃၅%(-၀.၄၅) 1D
စက် ၂၉, GMT-၄ ၁၂:၅၃:၁၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၃၃.၂၁ US$
High
၃၃.၅၄ US$
Low
၃၂.၇၀ US$
Mkt. cap
၁၉၆.၈၄ ဋေ
Avg. vol.
၉.၄၂ သိန်း
Volume
၈.၂၇ သောင်း
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၇.၀၁ US$
Beta
၀.၆၀
Shares outstanding
၅.၉၇ ကုဋေ
No. of employees
၅၄၀
Open
၃၃.၂၁ US$
High
၃၃.၅၄ US$
Low
၃၂.၇၀ US$
Mkt. cap
၁၉၆.၈၄ ဋေ
Avg. vol.
၉.၄၂ သိန်း
Volume
၈.၂၇ သောင်း
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၇.၀၁ US$
Beta
၀.၆၀
Shares outstanding
၅.၉၇ ကုဋေ
No. of employees
၅၄၀
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc